Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

46.18
-0.1700-0.37%
Post-market: 46.180.00000.00%17:31 EDT
Volume:501.45K
Turnover:23.29M
Market Cap:3.24B
PE:-14.84
High:47.30
Open:46.74
Low:46.00
Close:46.35
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Aug 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 19, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 03, 2022

Major Issues Report

8-K - Current report